Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company focused on CNS disorders, has announced its participation in three upcoming investor conferences. Sharon Mates, Ph.D., CEO and Chairman, will present at:

• Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 10:00 a.m. ET
• Baird's 2024 Global Healthcare Conference on September 11, 2024, at 11:25 a.m. ET
• 2024 Cantor Global Healthcare Conference on September 18, 2024, at 10:55 a.m. ET

All conferences will take place in New York, NY. Live and archived webcasts of the presentations will be available on the company's website under the Investors section.

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024 at 10:00 a.m. ET in New York, NY

Baird’s 2024 Global Healthcare Conference
Wednesday, September 11, 2024 at 11:25 a.m. ET in New York, NY

2024 Cantor Global Healthcare Conference
Wednesday, September 18, 2024 at 10:55 a.m. ET in New York, NY

A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When is Intra-Cellular Therapies (ITCI) presenting at the Morgan Stanley Global Healthcare Conference?

Intra-Cellular Therapies (ITCI) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 10:00 a.m. ET in New York, NY.

Who will be representing Intra-Cellular Therapies (ITCI) at the upcoming investor conferences?

Sharon Mates, Ph.D., Chief Executive Officer and Chairman of Intra-Cellular Therapies (ITCI), will be presenting at the three upcoming investor conferences.

How can I access the webcasts of Intra-Cellular Therapies' (ITCI) presentations?

Live and archived webcasts of Intra-Cellular Therapies' (ITCI) presentations can be accessed under 'Events & Presentations' in the Investors section of the company's website at www.intracellulartherapies.com.

What is the focus of Intra-Cellular Therapies (ITCI) as a biopharmaceutical company?

Intra-Cellular Therapies (ITCI) is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.

When is Intra-Cellular Therapies (ITCI) presenting at the Cantor Global Healthcare Conference?

Intra-Cellular Therapies (ITCI) is presenting at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:55 a.m. ET in New York, NY.